Switzerland · Investor

Novartis

Last cheque observed Sep 2026; 103 cheques on record.

Deploying nowVC firm

Series AVentureSeries BAnalyticsHealthcareLocal

Deploying now
21%of best year4cheques in 12 months, 103 on record
Since the last cheque55days00hrs00min00sec
Median round$37MRounds led2 of 103Sole investor8 roundsExits1 from the portfolioMostly inUnited States, 63%
Pitch Novartis

Novartis highlights

  1. 01

    4 cheques in the last 12 months

  2. 02

    Mostly Series A and Venture: 58% of its rounds

  3. 03

    Sole investor in 8 rounds, median $55M

  4. 04

    1 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
AnalyticsHealthcareLocal
Based in
Basel, Switzerland
Cold pitches
Not stated

The record

Every round we can evidence, newest first103 appearances

  1. 2026

    3 rounds

  2. Sept
    Intellia TherapeuticsDebt · US$400MWith 3 others
  3. Jul
    FreenomeUS$240MWith 4 others
  4. Apr
    PatientoryVenture · US$500KWith 2 others
  5. 2025

    15 rounds

  6. Dec
    Relation TherapeuticsVenture · GB$26MWith 5 others
  7. Oct
    DeciphexDebt · IE · Seroba Life Sciences$18MWith 2 others
  8. Oct
    Arcus BiosciencesUS$250MWith 3 others
  9. Oct
    Rani TherapeuticsUS$60MWith 3 others
  10. Oct
    C4 TherapeuticsUS$125MWith 3 others
  11. Oct
    Adicet BioUS$80MWith 2 others
  12. Oct
    OctaveVenture · USUndisclosedWith 3 others
  13. Jun
    IKAS Industrial AutomationVentureUndisclosedWith 1 other
  14. Apr
    Granite BioSeries B · US · Silicon Canals$70MWith 3 others
  15. Mar
    OctaveSeries C · US$32MWith 2 others
  16. Mar
    XealthVenture · USUndisclosedWith 2 others
  17. Feb
    Jiamai sharesVenture$14MWith 1 other
  18. Jan
    DeciphexSeries C · IE · Seroba Life Sciences$32MWith 9 others
  19. Jan
    RhygazeSeries A · CH$86MWith 2 others
  20. Jan
    Alesta TherapeuticsSeries A · NL · Firms' own news pages$67MWith 6 others
  21. 2024

    15 rounds

  22. Dec
    CitryllSeries B · NL · Silicon Canals$90MLed
  23. Dec
    CleerlySeries C · US · TechCrunch$106MWith 4 others
  24. Dec
    Credence MedSystemsVenture · US$13MWith 1 other
  25. Dec
    Borealis BiosciencesSeries A · CA$30MWith 1 other
  26. Oct
    LOQUS23 THERAPEUTICSSeries A · GB$46MWith 2 others
  27. Sept
    ONL TherapeuticsSeries D · US$65MWith 1 other
  28. Sept
    EpsilogenSeries B · GB$16MWith 2 others
  29. Sept
    Aktis OncologySeries B · US$175MWith 4 others
  30. Jul
    PatientoryVenture · USUndisclosedWith 2 others
  31. Jul
    Dren BioVenture · US$25MWith 4 others
  32. Jul
    ParrotsGrant · US$20KWith 3 others
  33. Apr
    FundaMental PharmaSeed · DE$2.9MSole investor
  34. Feb
    LightshipSeries C · US$17MWith 1 other
  35. Jan
    AravaxSeries B · AU$22MWith 3 others
  36. Jan
    Enterprise TherapeuticsSeries B · GB$33MWith 3 others
  37. 2023

    10 rounds

  38. Oct
    HolmuskVenture · SG$30MWith 1 other
  39. Sept
    HykuSeed · US$56MWith 3 others
  40. Aug
    Poseida TherapeuticsUS$50MWith 4 others
  41. Aug
    Poseida TherapeuticsUS$25MWith 4 others
  42. Jul
    Caribou BiosciencesUS$125MWith 4 others
  43. Jul
    TestCardVenture · GBUndisclosedWith 2 others
  44. Jun
    RxLightningSeries A · US$18MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 64 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

2+funds on filenumbered funds in its name

What they claim to have backed

From their own portfolio page (on their website)

0 of 1 we have independently watched raise

Live

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

LumenosBought by Anthem Inc (former WellPoint, Inc.)UndisclosedMay 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

Admune TherapeuticsUndisclosedOct 2015
Spinifex Pharmaceuticals$200MJun 2015
CoStim PharmaceuticalsUndisclosedFeb 2014
Corthera$620MDec 2009
Protez Pharmaceuticals$400MJun 2008

Who they invest alongside

The investors most often in the same rounds as Novartis. A count of rooms they were both in, not a relationship either has claimed.

Forbion Capital PartnersPrivate equity6rounds togetherRA Capital ManagementPrivate equity6rounds togetherVersant VenturesVC firm6rounds togetherAtlas VentureVC firm4rounds togetherDeerfieldVC firm4rounds togetherFidelityVC firm4rounds togetherOrbiMedPrivate equity4rounds togetherPerceptive AdvisorsAsset manager4rounds togetherRTW Investments LLCGrowth equity4rounds togetherSR OneCorporate VC4rounds together5AM VenturesVC firm3rounds togetherCormorant Asset ManagementPrivate equity3rounds together

Recently backed

The latest companies Novartis put money into.

Intellia Therapeutics$400M · Sept 2026Freenome$240M · Jul 2026Deciphex$18M · Oct 2025Arcus Biosciences$250M · Oct 2025C4 Therapeutics$125M · Oct 2025Adicet Bio$80M · Oct 2025

Quick answers about Novartis

What does Novartis invest in?

Novartis invests most often at Series A and Venture (58% of the rounds on record), in sectors such as Analytics, Healthcare and Local.

How active is Novartis?

103 investments on record, 4 of them in the last 12 months, and it led 2. The most recent was in Sept 2026.

What has Novartis invested in recently?

Its most recent investments on record: Intellia Therapeutics (Debt, Sept 2026), Freenome (Undisclosed round, Jul 2026) and Patientory (Venture, Apr 2026).

How big are Novartis's cheques?

The median round it joins is $37M.

Does Novartis lead rounds?

Sometimes: it led 2 of its 103 investments on record (2%).

Where does Novartis invest?

Most of the companies it backs are in the United States (63%), the United Kingdom (13%) and Ireland (5%).

Is Novartis investing now?

Yes: it is actively investing, with 4 investments in the last 12 months.

Who does Novartis invest alongside?

Most often Forbion Capital Partners (6 rounds together), RA Capital Management (6 rounds together) and Versant Ventures (6 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it